EVA SASALA: Open Payments
NPI 1053346429 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 27 payments from 15 companies in 2025. Trend: 2023 $269 · 2024 $543 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $69 |
| Dexcom, Inc. | 2 | $47 |
| PFIZER INC. | 3 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| SANOFI PASTEUR INC. | 2 | $32 |
| ABBVIE INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
Products named: ELIQUIS, SHINGRIX, Dexcom G6 Transmitter, GVOKE HYPOPEN, Rybelsus, CAPLYTA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, VRAYLAR.
Industry payments across TN — which companies pay providers there.
